Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP201208.RAfhLnvV0H7f-v4h39u7saVq55O6uHJJ7w1ThR7MxsMj0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP201208.RAfhLnvV0H7f-v4h39u7saVq55O6uHJJ7w1ThR7MxsMj0130_assertion type Assertion NP201208.RAfhLnvV0H7f-v4h39u7saVq55O6uHJJ7w1ThR7MxsMj0130_head.
- NP201208.RAfhLnvV0H7f-v4h39u7saVq55O6uHJJ7w1ThR7MxsMj0130_assertion description "[From a clinical standpoint, it is critical to identify MM patients carrying the t(4;14) translocation, which is present in 15% of myelomas and is associated with dysregulation of WHSC1/MMSET and often FGFR3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP201208.RAfhLnvV0H7f-v4h39u7saVq55O6uHJJ7w1ThR7MxsMj0130_provenance.
- NP201208.RAfhLnvV0H7f-v4h39u7saVq55O6uHJJ7w1ThR7MxsMj0130_assertion evidence source_evidence_literature NP201208.RAfhLnvV0H7f-v4h39u7saVq55O6uHJJ7w1ThR7MxsMj0130_provenance.
- NP201208.RAfhLnvV0H7f-v4h39u7saVq55O6uHJJ7w1ThR7MxsMj0130_assertion SIO_000772 22160056 NP201208.RAfhLnvV0H7f-v4h39u7saVq55O6uHJJ7w1ThR7MxsMj0130_provenance.
- NP201208.RAfhLnvV0H7f-v4h39u7saVq55O6uHJJ7w1ThR7MxsMj0130_assertion wasDerivedFrom befree-20140225 NP201208.RAfhLnvV0H7f-v4h39u7saVq55O6uHJJ7w1ThR7MxsMj0130_provenance.
- NP201208.RAfhLnvV0H7f-v4h39u7saVq55O6uHJJ7w1ThR7MxsMj0130_assertion wasGeneratedBy ECO_0000203 NP201208.RAfhLnvV0H7f-v4h39u7saVq55O6uHJJ7w1ThR7MxsMj0130_provenance.